Methicillin-resistant Staphylococcus aureus in HIV-infected patients

Abstract

Concordant with the emergence of methicillin-resistant Staphylococcus aureus (MRSA) in the community setting, colonization and infections with this pathogen have become a prevalent problem among the human immunodeficiency virus (HIV)-positive population. A variety of different host- and, possibly, pathogen-related factors may play a role in explaining the increased prevalence and incidence observed. In this article, we review pathophysiology, epidemiology, clinical manifestations, and treatment of MRSA in the HIV-infected population.

Keywords:

• MRSA
• Staphylococcus aureus
• HIV
• resistance

Acknowledgements

This study was financially supported, in part, by the NIH Fogarty International Center (D43TW007124 and D43TW007124-06S1) and the Atlanta Clinical and Translational Science Institute (NIH/NCRR UL1RR025008) (Kempker).

Disclosure

None of the authors in this manuscript have any conflicts of interest to disclose.